MetaboVia Supplement Explained — 5-Ingredient Science Behind Multi-Pathway Metabolic Support
How to Evaluate a Metabolic Wellness Supplement: A 5-Mechanism Scientific Framework
An evidence-based scientific guide to MetaboVia's multi-ingredient formula — examining 5 biological mechanisms and 5 scientifically contextualized ingredients for metabolic wellness, healthy energy utilization, and the body's natural processes for fat and carbohydrate metabolism.
Published: May 3, 2026, Written by Nalin Siriwardhana, PhD, FACN Published by NUTRITUNES® Science of Supplements
This article is for educational purposes and is grounded in peer-reviewed scientific literature cited throughout. Individual responses to dietary supplements vary.
Compliance note: This article discusses biological processes associated with metabolic function, glucose handling, and energy utilization, and does not imply that any dietary supplement can diagnose, treat, cure, or prevent disease. MetaboVia is not a weight-loss product and is not intended to replace diet, exercise, or medical care.
At a glance: A well-designed metabolic wellness formula should address more than one biological pathway. The strongest supplement labels typically combine compounds that support cellular energy regulation, glucose handling, insulin signaling, carbohydrate metabolism, and thermogenesis — each in disclosed, clinically contextualized doses with bioavailable forms.
The Case for a Layered Metabolic Wellness Approach
The body's metabolism is not a single switch — it's an integrated network of biochemical pathways spanning the liver, muscles, adipose tissue, gut, and nearly every cell in the body. Glucose handling, insulin signaling, fatty acid oxidation, carbohydrate metabolism, and thermogenesis all influence one another. When these pathways function efficiently, the body uses energy well, manages nutrient flow gracefully, and adapts to the demands of daily life. When they become sluggish or imbalanced — for reasons that include age, sleep quality, stress, dietary patterns, and physical activity — many people notice changes in how their body responds to food, energy levels throughout the day, and other aspects of metabolic function.
Single-ingredient approaches often do not reflect the biological complexity of metabolic regulation, which involves multiple overlapping pathways. What the published research supports is a layered nutritional approach: one that combines compounds studied in relation to cellular energy regulation, ingredients associated with healthy glucose handling, micronutrients with documented roles in insulin signaling, and botanical compounds investigated for their roles in carbohydrate metabolism and thermogenesis.
That is the scientific logic behind multi-ingredient metabolic support formulas — and the framework used here to evaluate MetaboVia.
This article focuses on mechanisms, ingredient forms, dosage context, and the strength of the available evidence.
Quick Selection Checklist: What to Look for on the Label
- Berberine (from Berberis species) in a standardized, advanced extract form (such as Metaberine®) at a clinically contextualized dose
- Banaba (Lagerstroemia speciosa) leaf extract standardized to corosolic acid content
- Chromium in a bioavailable form (picolinate) at a meaningful dose
- Gymnema (Gymnema sylvestre) standardized to gymnemic acid content
- Grains of Paradise (Aframomum melegueta) at the dose range used in published clinical research
- GMP-certified manufacturing in an FDA-registered facility
- No proprietary blends that obscure individual ingredient doses
- Transparent labeling of ingredient forms (not just generic names)
If you remember one thing: A layered metabolic formula may offer broader nutritional support than a single-ingredient product because it is designed to support multiple biological pathways simultaneously — though no supplement replaces sound nutrition, regular physical activity, and appropriate medical care.
Who This May Be For
This article is written for adults seeking to understand the science behind nutritional support for metabolic wellness. It may be particularly relevant for those interested in evidence-based nutritional approaches to support healthy metabolism, glucose handling, and energy utilization as a complement to a balanced diet and regular physical activity — or who want to evaluate what the available evidence says before choosing a supplement. It is not medical advice, and it is not a substitute for evaluation by a licensed healthcare provider. MetaboVia is not a weight-loss product.
5 Key Mechanisms — 5 Scientifically Selected Ingredients
The MetaboVia formula is designed to map across five distinct physiological parameters. Each section below explains why that parameter matters biologically, identifies the relevant ingredient, its specific form and dose, and offers an honest assessment of the published evidence.
Mechanism 1 — Cellular Energy Regulation: Berberine (Metaberine®)
Why it matters: AMP-activated protein kinase (AMPK) is one of the most extensively studied regulatory enzymes in metabolic biochemistry. Often described in the scientific literature as a cellular "energy sensor," AMPK is activated when cellular energy levels are low. AMPK activation has been associated in mechanistic and preclinical research with changes in cellular energy use, including glucose uptake by cells, fatty acid oxidation, modulation of lipogenesis, and mitochondrial activity. Supporting cellular energy regulation through AMPK signaling is a primary focus in nutritional science related to metabolic wellness.
Ingredient: Berberine, as Metaberine® advanced berberine extract (200 mg)
Berberine is among the most extensively studied natural compounds for AMPK activation. A landmark mechanistic study in Diabetes (Lee YS et al., 2006, PMID: 16873688) reported that berberine activates AMPK with associated metabolic effects in cellular and animal models. A subsequent study in Diabetes (Turner N et al., 2008, PMID: 18285556) further characterized berberine's mechanism, identifying mitochondrial respiratory complex I inhibition as one upstream trigger of AMPK activation — providing a mechanistic foundation for berberine's downstream metabolic effects.
The human clinical evidence base for berberine has expanded considerably. A widely cited human RCT in Metabolism (Yin J et al., 2008, PMID: 18442638) examined berberine's effects on glucose and lipid metabolism markers in adults. A meta-analysis in the Journal of Ethnopharmacology (Lan J et al., 2015, PMID: 25498346) — pooling data from multiple human RCTs — examined berberine's effects on glucose, lipid, and blood pressure parameters. A systematic review in Evidence-Based Complementary and Alternative Medicine (Dong H et al., 2012, PMID: 23118793) similarly examined berberine across multiple human trials. AMPK activation is one of the leading proposed mechanisms used to explain berberine's observed effects in human studies.
The Metaberine® form used in MetaboVia is a standardized advanced berberine extract. Standardization matters because berberine is known to have variable absorption — some preparations have addressed this through advanced extraction or formulation approaches.
Evidence grade: Strong mechanistic and preclinical evidence for AMPK activation; substantial human clinical evidence for berberine's effects on glucose and lipid metabolism markers across multiple RCTs and meta-analyses. Most human research has been conducted in populations with metabolic concerns; applicability to healthy adults is supportive but warrants continued research.
What to look for: A standardized berberine extract specifying the active form (HCl, sulfate, or branded extract such as Metaberine®); transparent dose disclosure rather than proprietary blend.
Key takeaway: Berberine is one of the most extensively studied natural compounds in metabolic nutrition. Its association with AMPK pathway activation and its consistent appearance across human clinical research for glucose and lipid metabolism markers make it a foundational ingredient for metabolic wellness formulas.
References to clinical research describe published study findings and are provided for scientific context. They do not constitute claims about what any NUTRITUNES® product will do for any individual.
Mechanism 2 — Healthy Glucose Transport: Banaba Leaf Extract
Why it matters: How the body manages glucose after meals is foundational to metabolic health. After eating, dietary carbohydrates break down into glucose, which enters the bloodstream and is transported into cells — primarily through GLUT4 glucose transporters in muscle and adipose tissue. The efficiency of this transport process is a key parameter of metabolic function.
Ingredient: Banaba (Lagerstroemia speciosa) leaf extract (300 mg)
Banaba is a tropical tree whose leaves have been used in traditional Filipino and Southeast Asian wellness practice for centuries. Modern research has identified corosolic acid as a primary bioactive compound. A pilot human clinical study in the Journal of Ethnopharmacology (Judy WV et al., 2003, PMID: 12787964) examined a standardized banaba extract in adults, reporting findings related to glucose response. A comprehensive review in Evidence-Based Complementary and Alternative Medicine (Miura T et al., 2012, PMID: 22919422) summarized the mechanistic and preclinical research base for banaba and corosolic acid, including its proposed effects on glucose transport mechanisms.
A review in Evidence-Based Complementary and Alternative Medicine (Klein G et al., 2007, PMID: 18227906) further examined the broader research literature on banaba's metabolic activities.
The mechanistic and cellular evidence on corosolic acid is more extensive than the controlled human clinical evidence base — a distinction worth holding when evaluating this ingredient.
Evidence grade: Moderate. Strong mechanistic and preclinical evidence; smaller and more variable controlled human clinical evidence base. Banaba is generally well-tolerated when standardized and used at studied doses.
What to look for: Standardization to corosolic acid percentage (typically 1-2%); reputable extraction source; transparent dose disclosure.
Key takeaway: Banaba leaf extract has been studied for its role in glucose handling, with mechanistic research providing the foundation for its inclusion in metabolic support formulas. The 300 mg dose in MetaboVia aligns with typical research-context dosing.
Mechanism 3 — Insulin Signaling Support: Chromium Picolinate
Why it matters: Insulin is the hormone that signals cells to take up glucose from the blood. How efficiently cells respond to insulin is a key aspect of metabolic function — and chromium is a trace mineral that plays a documented role in this signaling pathway. Research has characterized a small chromium-binding peptide called chromodulin, which is involved in amplifying insulin receptor signaling at the cellular level.
Ingredient: Chromium (as Chromium Picolinate) — 200 mcg
Chromium picolinate is among the most extensively researched mineral forms in metabolic nutrition. A foundational review in the Journal of Nutrition (Vincent JB, 2000, PMID: 10736319) examined chromium biochemistry, including its proposed mechanism through chromodulin and insulin receptor signaling. A review in the Journal of the American College of Nutrition (Anderson RA, 1998, PMID: 9853533) summarized the broader research on chromium and glucose intolerance.
A systematic review and meta-analysis in the Journal of Clinical Pharmacy and Therapeutics (Suksomboon N et al., 2014, PMID: 24635480) examined chromium supplementation across multiple human RCTs, providing one of the more comprehensive analyses of chromium's clinical research base in metabolic markers.
Chromium picolinate is the form chosen for its bioavailability advantage over inorganic forms such as chromium chloride, and is the form used in much of the clinical research literature.
Evidence grade: Strong mechanistic evidence; substantial human clinical evidence base across multiple RCTs and meta-analyses. As with most metabolic ingredients, individual benefit may depend on baseline status, dietary context, and other factors.
What to look for: Chromium as picolinate (preferred bioavailable form) rather than chromium chloride or oxide; dose at or near 200 mcg, which is the most common research-context dose.
Key takeaway: Chromium picolinate's role in insulin signaling — through the chromodulin mechanism — makes it one of the better-researched minerals in metabolic nutrition. Its inclusion at 200 mcg aligns with research-context dosing.
Mechanism 4 — Carbohydrate Metabolism Support: Gymnema Sylvestre
Why it matters: Beyond glucose transport, the body's broader handling of dietary carbohydrates — including intestinal absorption dynamics and downstream glucose metabolism — influences overall metabolic function. Botanical compounds with documented effects on carbohydrate-related pathways have a long history in traditional wellness practice and an expanding modern research base.
Ingredient: Gymnema sylvestre leaf extract (100 mg)
Gymnema sylvestre has one of the longest documented histories in traditional wellness practice — used in Ayurvedic medicine for centuries. The Hindi name "gurmar" translates to "sugar destroyer," reflecting traditional observations about its effects on sweet taste perception and carbohydrate handling. Modern research has begun to characterize gymnema's mechanisms.
The active compounds — gymnemic acids — have been studied for two distinct effects. First, gymnemic acids temporarily interact with sweet-taste receptors on the tongue. This is a direct contact effect, primarily relevant to traditional preparations rather than encapsulated supplements. Second, beyond taste, peer-reviewed research has examined gymnema's effects on intestinal carbohydrate handling and glucose markers.
Foundational human clinical research includes work published in the Journal of Ethnopharmacology (Baskaran K et al., 1990, PMID: 2259217) and (Shanmugasundaram ER et al., 1990, PMID: 2259215) — both examining gymnema leaf extract preparations in clinical contexts. A more recent systematic review in the Journal of the Science of Food and Agriculture (Pothuraju R et al., 2014, PMID: 24166097) summarized the broader research base on gymnema across metabolic-related endpoints.
The modern human clinical evidence base on gymnema includes mostly older foundational studies, with continuing research building on its centuries of documented traditional use.
Evidence grade: Moderate. Combines centuries of traditional use with foundational human clinical research and modern mechanistic studies. Direct controlled human evidence on encapsulated extracts at specific doses is more limited than for berberine or chromium.
What to look for: Gymnema sylvestre leaf extract; standardization to gymnemic acids when specified; transparent ingredient sourcing.
Key takeaway: Gymnema sylvestre carries a notable combination of evidence: centuries of documented traditional use in Ayurvedic medicine alongside modern research examining its mechanisms in carbohydrate handling. Its inclusion in metabolic formulas reflects both heritage and investigated mechanism.
Mechanism 5 — Thermogenesis and Energy Expenditure: Grains of Paradise
Why it matters: The human body has two primary types of fat tissue: white adipose tissue (which stores energy) and brown adipose tissue (which generates heat by burning energy in a process called thermogenesis). Research over the past 15 years has confirmed that adults retain functional brown adipose tissue, and its role in metabolic function has emerged as an area of active research. Foundational work in New England Journal of Medicine (Cypess AM et al., 2009, PMID: 19357406) and (van Marken Lichtenbelt WD et al., 2009, PMID: 19357405) established the presence of functional brown adipose tissue in adult humans, opening a new research frontier in thermogenesis-related nutritional science.
Ingredient: Grains of Paradise (Aframomum melegueta) extract — 40 mg
Grains of Paradise is a West African spice in the ginger family. A landmark human clinical study in the British Journal of Nutrition (Sugita J et al., 2013, PMID: 23308394) examined Grains of Paradise extract's effects on brown adipose tissue activity and whole-body energy expenditure in healthy adult men, using PET imaging to assess BAT activity. A follow-up study in the Journal of Nutritional Science and Vitaminology (Sugita J et al., 2014, PMID: 24759256) examined daily ingestion of Grains of Paradise extract over a longer period.
Brown adipose tissue research is a relatively young and rapidly developing field of metabolic science, and Grains of Paradise represents one of the more interesting natural compounds being investigated for its role in supporting thermogenesis. The 40 mg dose in MetaboVia aligns with doses used in published clinical research.
Evidence grade: Moderate. Published human clinical research using imaging-based endpoints provides direct evidence, though sample sizes have been smaller than for ingredients with longer research histories. The research base is growing as the broader BAT field develops.
What to look for: Standardized Grains of Paradise extract; dose at or near 40 mg, which aligns with clinical research dosing.
Key takeaway: Grains of Paradise represents an emerging area of metabolic science — its inclusion in MetaboVia at the 40 mg research-context dose reflects engagement with active scientific developments in thermogenesis research.
How MetaboVia Maps to This Evidence Framework
| Ingredient | Dose | Form | Evidence-Based Context | Honest Notes |
|---|---|---|---|---|
| Berberine | 200 mg | Metaberine® advanced extract | AMPK activation; multiple human RCTs and meta-analyses | Strong overall evidence; most studies in metabolic-concern populations |
| Banaba | 300 mg | Standardized leaf extract | Studied for glucose handling and corosolic acid mechanisms | Strong mechanistic data; smaller controlled human studies |
| Chromium Picolinate | 200 mcg | Picolinate form | Insulin signaling via chromodulin; multiple human RCTs and meta-analyses | Strong evidence base; bioavailable form |
| Gymnema Sylvestre | 100 mg | Leaf extract | Carbohydrate handling; foundational human clinical research | Moderate; combines traditional use with modern mechanistic study |
| Grains of Paradise | 40 mg | Aframomum melegueta extract | Brown adipose tissue activation; thermogenesis | Moderate; emerging field with smaller but direct human evidence |
MetaboVia includes ingredients at doses that align with commonly studied ranges or branded research-context dosing levels. Each ingredient was selected for its individual research base, mechanism of action, and complementary role within the multi-pathway design. The MetaboVia formula as a complete five-ingredient combination has not been studied in a single dedicated clinical trial — the supporting evidence is for individual ingredients. No supplement delivers guaranteed outcomes, and individual responses vary.
Summary Table: Evidence-Based Standard vs. MetaboVia
| Criterion | Evidence-Based Standard | MetaboVia |
|---|---|---|
| Berberine form | Standardized, bioavailable extract | Metaberine® advanced berberine extract ✓ |
| Banaba standardization | Corosolic acid disclosure | Standardized leaf extract ✓ |
| Chromium form | Picolinate (preferred bioavailable) | Chromium Picolinate ✓ |
| Gymnema form | Standardized leaf extract | Gymnema sylvestre leaf extract ✓ |
| Grains of Paradise dose | Clinical research dose range | 40 mg (research-context aligned) ✓ |
| Manufacturing | GMP; FDA-registered | GMP-compliant; made in USA ✓ |
| Capsule type | Vegan; non-GMO | Vegan; non-GMO ✓ |
| Free-from labeling | Allergen disclosure | Free from gluten, soy, lactose, BSE ✓ |
FAQ
Q: Is MetaboVia a weight-loss supplement? No. MetaboVia is a dietary supplement formulated to support metabolic function, healthy energy utilization, and the body's natural processes for fat and carbohydrate metabolism — as part of a balanced lifestyle that includes diet and physical activity. It is not a weight-loss product, is not intended to replace diet or exercise, and is not a treatment for any health condition. Individual responses vary. A licensed healthcare provider is the appropriate person to guide weight or metabolic health decisions.
Q: What makes Metaberine® different from standard berberine? Metaberine® is a standardized advanced berberine extract designed for consistent quality and bioavailability. Standardization matters because berberine has historically been associated with variable absorption — some advanced extract approaches address this. Standard berberine HCl preparations also have substantial research support; the form chosen for any supplement should be transparent on the label.
Q: Why include both Banaba and Chromium Picolinate? Aren't they both for glucose? They support different aspects of glucose metabolism. Banaba's research base focuses on glucose transport mechanisms (how glucose moves into cells). Chromium picolinate's research base focuses on insulin signaling (how cells respond to insulin). These are mechanistically complementary rather than redundant — supporting different points along the same overall pathway.
Q: What does "standardized leaf extract" mean and why does it matter? Standardized extracts are characterized to deliver a consistent percentage of active compounds. For Banaba, this typically means standardization to corosolic acid; for Gymnema, it means standardization to gymnemic acids. Standardization reduces batch-to-batch variability and provides more predictable nutritional support compared to non-standardized "whole leaf" preparations.
Q: Why is the Grains of Paradise dose only 40 mg when other ingredients are higher? Effective dosing in supplements is mechanism-dependent, not weight-dependent. The 40 mg dose for Grains of Paradise aligns with the doses used in published human clinical research examining this compound's effects on thermogenesis. Higher doses are not necessarily better — research-context dosing reflects what published studies have actually examined.
Q: How long should I take MetaboVia to evaluate it? MetaboVia is formulated for daily use as part of a healthy lifestyle. Metabolic processes adapt gradually, and the published research on individual ingredients varies in study duration from days to several months. Consistent daily use alongside balanced nutrition and regular physical activity is the appropriate context. A licensed healthcare provider can help establish appropriate evaluation timeframes for your individual circumstances.
Q: Should I consult a clinician before starting this supplement? Yes — particularly if you are pregnant or breastfeeding, take prescription medications (including any medications affecting blood sugar, blood pressure, or anticoagulation), or have a history of liver, kidney, thyroid, or metabolic health conditions. Berberine specifically may interact with several medication classes and should be discussed with a healthcare provider before use.
Q: What should I look for on any metabolic wellness supplement label to assess quality? Transparent individual ingredient doses (no proprietary blends), standardized extracts with form-specific notation (Metaberine®, Chromium Picolinate, etc.), GMP manufacturing in an FDA-registered facility, third-party certifications when available, bioavailable mineral forms (citrate or picolinate over oxide), and clear allergen and free-from labeling.
When to Talk to a Clinician
Dietary supplements are not a substitute for medical evaluation. Seek professional guidance if you are experiencing symptoms requiring clinical assessment; if you take prescription medications (particularly those affecting blood sugar, blood pressure, or anticoagulation); if you are pregnant or nursing; or if you have a history of liver, kidney, thyroid, or metabolic health conditions. A clinician familiar with integrative or nutritional medicine can help assess what role, if any, a supplement like MetaboVia may play as part of a broader wellness strategy.
The Bottom Line
The biological complexity of metabolic regulation is multilayered. A well-designed nutritional formula should reflect that complexity. The strongest case for a layered metabolic wellness supplement rests on supporting cellular energy regulation, healthy glucose transport, insulin signaling, carbohydrate metabolism, and thermogenesis in parallel — with ingredient forms and doses grounded in the published scientific literature.
MetaboVia is formulated to support these biological pathways through Metaberine® advanced berberine extract for AMPK-related cellular energy regulation, banaba leaf extract for glucose transport support, chromium picolinate for insulin signaling support, gymnema sylvestre for carbohydrate metabolism support, and Grains of Paradise extract at the research-context dose for thermogenesis support. It is produced in a GMP-compliant, FDA-registered U.S. facility.
No single supplement addresses every aspect of health — and no credible science article would suggest otherwise. Used as a complement to balanced nutrition, regular physical activity, adequate sleep, and appropriate clinical care, MetaboVia reflects a formula architecture grounded in mechanism-first thinking.
→ NUTRITUNES Science of Supplements Hub
References
- Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55(8):2256-2264. PMID: 16873688. https://pubmed.ncbi.nlm.nih.gov/16873688/
- Turner N, Li JY, Gosby A, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to lower glucose. Diabetes. 2008;57(5):1414-1418. PMID: 18285556. https://pubmed.ncbi.nlm.nih.gov/18285556/
- Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. PMID: 18442638. https://pubmed.ncbi.nlm.nih.gov/18442638/
- Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Journal of Ethnopharmacology. 2015;161:69-81. PMID: 25498346. https://pubmed.ncbi.nlm.nih.gov/25498346/
- Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2012;2012:591654. PMID: 23118793. https://pubmed.ncbi.nlm.nih.gov/23118793/
- Judy WV, Hari SP, Stogsdill WW, et al. Antidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves in Type II diabetics. Journal of Ethnopharmacology. 2003;87(1):115-117. PMID: 12787964. https://pubmed.ncbi.nlm.nih.gov/12787964/
- Miura T, Takagi S, Ishida T. Management of diabetes and its complications with banaba (Lagerstroemia speciosa L.) and corosolic acid. Evidence-Based Complementary and Alternative Medicine. 2012;2012:871495. PMID: 22919422. https://pubmed.ncbi.nlm.nih.gov/22919422/
- Klein G, Kim J, Himmeldirk K, Cao Y, Chen X. Antidiabetes and anti-obesity activity of Lagerstroemia speciosa. Evidence-Based Complementary and Alternative Medicine. 2007;4(4):401-407. PMID: 18227906. https://pubmed.ncbi.nlm.nih.gov/18227906/
- Vincent JB. The biochemistry of chromium. Journal of Nutrition. 2000;130(4):715-718. PMID: 10736319. https://pubmed.ncbi.nlm.nih.gov/10736319/
- Anderson RA. Chromium, glucose intolerance and diabetes. Journal of the American College of Nutrition. 1998;17(6):548-555. PMID: 9853533. https://pubmed.ncbi.nlm.nih.gov/9853533/
- Suksomboon N, Poolsup N, Yuwanakorn A. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes. Journal of Clinical Pharmacy and Therapeutics. 2014;39(3):292-306. PMID: 24635480. https://pubmed.ncbi.nlm.nih.gov/24635480/
- Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. Journal of Ethnopharmacology. 1990;30(3):295-300. PMID: 2259217. https://pubmed.ncbi.nlm.nih.gov/2259217/
- Shanmugasundaram ER, Rajeswari G, Baskaran K, et al. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. Journal of Ethnopharmacology. 1990;30(3):281-294. PMID: 2259215. https://pubmed.ncbi.nlm.nih.gov/2259215/
- Pothuraju R, Sharma RK, Chagalamarri J, Jangra S, Kumar Kavadi P. A systematic review of Gymnema sylvestre in obesity and diabetes management. Journal of the Science of Food and Agriculture. 2014;94(5):834-840. PMID: 24166097. https://pubmed.ncbi.nlm.nih.gov/24166097/
- Sugita J, Yoneshiro T, Hatano T, et al. Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in men. British Journal of Nutrition. 2013;110(4):733-738. PMID: 23308394. https://pubmed.ncbi.nlm.nih.gov/23308394/
- Sugita J, Yoneshiro T, Sugishima Y, et al. Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humans. Journal of Nutritional Science and Vitaminology (Tokyo). 2014;60(1):22-27. PMID: 24759256. https://pubmed.ncbi.nlm.nih.gov/24759256/
- Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. New England Journal of Medicine. 2009;360(15):1509-1517. PMID: 19357406. https://pubmed.ncbi.nlm.nih.gov/19357406/
- van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. New England Journal of Medicine. 2009;360(15):1500-1508. PMID: 19357405. https://pubmed.ncbi.nlm.nih.gov/19357405/
These statements have not been evaluated by the Food and Drug Administration. NUTRITUNES® supplements are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Individual responses to dietary supplements vary.
If you are experiencing symptoms requiring medical evaluation, consult a licensed healthcare professional promptly.